Lipella Pharmaceuticals Other Current Assets

Lipella Pharmaceuticals posts a other current assets of $220M as of September 2025. That compares with $730M in the prior-year period — down 69.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Lipella Pharmaceuticals's other current assets was $730M. The latest reading is $220M — a 69.2% year-over-year decrease (period ending September 2025). Use the history and growth charts on this page for a longer lookback.

Other Current Assets is one piece of Lipella Pharmaceuticals's financial statement story. At $220M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LIPO's other current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Lipella Pharmaceuticals's other metric pages and overview cover the third.